183 related articles for article (PubMed ID: 24896196)
1. CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients.
Do RK; McErlean A; Ang CS; DeMatteo RP; Abou-Alfa GK
Br J Radiol; 2014 Aug; 87(1040):20140024. PubMed ID: 24896196
[TBL] [Abstract][Full Text] [Related]
2. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
3. Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI.
Palm V; Sheng R; Mayer P; Weiss KH; Springfeld C; Mehrabi A; Longerich T; Berger AK; Kauczor HU; Weber TF
Cancer Imaging; 2018 Mar; 18(1):9. PubMed ID: 29490696
[TBL] [Abstract][Full Text] [Related]
4. Imaging features of primary and metastatic alveolar soft part sarcoma: single institute experience in 25 patients.
Sood S; Baheti AD; Shinagare AB; Jagannathan JP; Hornick JL; Ramaiya NH; Tirumani SH
Br J Radiol; 2014 Apr; 87(1036):20130719. PubMed ID: 24641199
[TBL] [Abstract][Full Text] [Related]
5. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
Bhaijee F; Locketz ML; Krige JE
S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
[TBL] [Abstract][Full Text] [Related]
6. Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging.
Ichikawa T; Federle MP; Grazioli L; Marsh W
Radiology; 2000 Oct; 217(1):145-51. PubMed ID: 11012437
[TBL] [Abstract][Full Text] [Related]
7. Fibrolamellar carcinoma of the liver.
Yamaguchi R; Tajika T; Kanda H; Nakanishi K; Kawanishi J
Hepatogastroenterology; 1999; 46(27):1706-9. PubMed ID: 10430327
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
9. Fibrolamellar hepatocellular carcinoma: multiphasic CT features of the primary tumor on pre-therapy CT and pattern of distant metastases.
Ganeshan D; Szklaruk J; Kaseb A; Kattan A; Elsayes KM
Abdom Radiol (NY); 2018 Dec; 43(12):3340-3348. PubMed ID: 29948061
[TBL] [Abstract][Full Text] [Related]
10. Imaging of non-central nervous system primitive neuroectodermal tumours: diagnostic features and correlation with outcome.
Dick EA; McHugh K; Kimber C; Michalski A
Clin Radiol; 2001 Mar; 56(3):206-15. PubMed ID: 11247698
[TBL] [Abstract][Full Text] [Related]
11. State-of-the-art MR Imaging of Uncommon Hepatocellular Tumours: Fibrolamellar Hepatocellular Carcinoma and Combined Hepatocellularcholangiocarcinoma.
Anysz-Grodzicka A; Podgorska J; Cieszanowski A
Curr Med Imaging Rev; 2019; 15(3):269-280. PubMed ID: 31989878
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
[TBL] [Abstract][Full Text] [Related]
13. Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management.
Stevens WR; Johnson CD; Stephens DH; Nagorney DM
AJR Am J Roentgenol; 1995 May; 164(5):1153-8. PubMed ID: 7717223
[TBL] [Abstract][Full Text] [Related]
14. Routine Staging Using Chest Computed Tomography in Workup of Treatment-Naïve Hepatocellular Carcinoma Prior to Locoregional Therapy: Is There a Need?
Leong PW; Pua U; Lim KS
Ann Acad Med Singap; 2017 Jul; 46(7):282-286. PubMed ID: 28821892
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
[TBL] [Abstract][Full Text] [Related]
16. Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma.
Burkill GJ; Mannion EM; Healy JC
Clin Radiol; 2001 Jan; 56(1):67-71. PubMed ID: 11162701
[TBL] [Abstract][Full Text] [Related]
17. [Imaging findings of fibrolamellar hepatocellular carcinoma].
Wang M; Cui Z; Yu G
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):128-30. PubMed ID: 11776854
[TBL] [Abstract][Full Text] [Related]
18. Extrahepatic metastases of hepatocellular carcinoma: A spectrum of imaging findings.
Becker AK; Tso DK; Harris AC; Malfair D; Chang SD
Can Assoc Radiol J; 2014 Feb; 65(1):60-6. PubMed ID: 24239313
[TBL] [Abstract][Full Text] [Related]
19. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature.
Alshareefy Y; Shen CY; Prekash RJ
Pathol Res Pract; 2023 Aug; 248():154655. PubMed ID: 37429175
[TBL] [Abstract][Full Text] [Related]
20. Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients.
Senthilnathan S; Memon K; Lewandowski RJ; Kulik L; Mulcahy MF; Riaz A; Miller FH; Yaghmai V; Nikolaidis P; Wang E; Baker T; Abecassis M; Benson AB; Omary RA; Salem R
Hepatology; 2012 May; 55(5):1432-42. PubMed ID: 22109811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
